Related Experiment Video
Updated: May 8, 2026
08:49
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Modelling propofol pharmacodynamics using BIS-guided anaesthesia
I Martín-Mateos1, J A Méndez Pérez, J A Reboso
1Universidad de La Laguna, La Laguna, Tenerife, Spain.
Anaesthesia
|September 3, 2013
Summary
This study modeled propofol pharmacodynamics during anesthesia using Schnider
Area of Science:
- Anesthesiology
- Pharmacokinetics
- Pharmacodynamics
Background:
- Total intravenous anesthesia (TIVA) relies on precise drug administration.
- Understanding propofol's concentration-effect relationship is crucial for safe TIVA.
- Remifentanil co-administration can influence anesthetic depth.
Purpose of the Study:
- To model propofol pharmacodynamics during TIVA using Schnider's pharmacokinetic model.
- To estimate key pharmacodynamic parameters (Ce50 and γ) for induction and maintenance phases.
- To investigate the influence of age and sex on propofol's effects.
Main Methods:
- Utilized Schnider's pharmacokinetic model to analyze data from 42 surgical patients.
- Adjusted the pharmacokinetic/pharmacodynamic model based on bispectral index (BIS) data.
- Estimated Ce50 (concentration for 50% effect) and γ (slope factor) for induction and maintenance.
Main Results:
- Distinct pharmacodynamic models were identified for propofol induction and maintenance.
- Higher propofol concentrations (Ce50) were required for induction (3.35 mg/L) compared to maintenance (2.23 mg/L).
- The concentration-effect slope (γ) was steeper during maintenance (1.58) than induction (1.24), indicating greater patient response.
Conclusions:
- Propofol's pharmacodynamic profile differs significantly between induction and maintenance phases.
- Age demonstrated a linear relationship with propofol's effect concentration (Ce50).
- Sex did not significantly impact the propofol pharmacokinetic/pharmacodynamic model.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:22Stages of General Anesthesia
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...